Global Cardiac Assist Devices Market Forecast up to 2025

March 2019 | 88 pages | ID: GAC0B320343EN
IHR Insights

Abstracts

Global Cardiac Assist Devices Market 2019–2025

[88 pages report] This market research report includes a detailed segmentation of the global cardiac assist devices market by product (Intra-Aortic Balloon Pump and Ventricular Assist Devices {Left Ventricular Assist Devices [LVAD], Right Ventricular Assist Devices [RVAD], and Biventricular Assist Devices [BIVAD]), and by region (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global Cardiac Assist Devices Market Research

Infoholic’s market research report predicts that the global cardiac assist devices market will grow at a CAGR of 11.6% during the forecast period. The market has witnessed steady growth in the past few years and the advancement in technology coupled with the introduction of novel products have augmented the acceptance of heart assist devices in the market. The market is fueled by upsurge in the incidence of heart failure, growing elderly population, and shortage of heart donors for transplantation.

The market continues to grow and the devices are most widely used for the functioning of heart in case of failure and weakened heart patients. The field is getting revolutionized with the availability of improved technology. The key market players are focusing towards approvals, new product launches, and targeting towards end-user’s perspective. The market generates the revenue from the key players operating in this field and some of them includes Abbott Laboratories, Berlin Heart GmbH, Maquet GmbH (Getinge AB), SynCardia Systems, LLC, and ReliantHeart, Inc.

According to Infoholic Research analysis, North America accounted for the largest share of the global cardiac assist devices market in 2018 and is expected to remain the leading region in terms of value during the forecast period.

According to American Heart Association, an estimated 92.1 million population in US have at least one type of CVD and by 2030 it is projected that close to 44% of the US adult population to have some form of CVD. Increasing incidence of cardiovascular diseases, promising reimbursement policies, presence of dominant vendors, and accessibility of advanced technologies will increase the demand and adoption of the cardiac assist devices in the region.

Europe is the second largest region in terms of cardiac assist devices market. Cardiovascular disease (CVD) causes 3.9 million deaths and over 1.8 million deaths in EU countries. In UK alone, around 60,000 new cases of advanced chronic heart failure are diagnosed every year out of which 40% die within a year.

Asia Pacific is expected to grow at mid-double digit CAGR during the forecast period, owing to factors such as growing healthcare expenditure, high prevalence of lifestyle related disorders, and increasing acceptance of advanced technologies in the market.

By Product:

• Intra-Aortic Balloon Pump (IABP)
• Ventricular Assist Devices (VAD)
  • Left Ventricular Assist Devices (LVAD)
  • Right Ventricular Assist Devices (RVAD)
  • Biventricular Assist Devices (BIVAD)
• Total Artificial Heart (TAH)

In 2018, the ventricular assist devices segment occupied the largest share and is expected to grow at mid-double digit CAGR during the forecast period. The ventricular assist devices market is further segmented into left ventricular assist devices, right ventricular assist devices, and biventricular assist devices. Among these, left ventricular assist devices occupied a major share and is expected to grow at high CAGR during the forecast period. Increasing number of patients suffering from last-stage heart failure, advancements in technology leading to better effectiveness & high survival rate, and decreased risk of the devices makes the segment the most common among other VAD devices.

By Regions:

• North America
• Europe
• Asia Pacific
• Rest of the World

The market is dominated by North America, followed by Europe and Asia Pacific. The US occupied the major share of the North American market due to the presence of key vendors and obtainability of advanced technologies.

Cardiac Assist Devices Market Research Competitive Analysis – The global cardiac assist devices market has massive growth opportunities in both developed and developing regions. The upgradation and advancements of devices will increase the competition among the market players. Many companies are concentrating on new approvals, funding, and development of new products related to cardiac assist device because of the increase in implantable procedures. For instance, Teleflex announced FDA approval for intra-aortic balloon pump in 2017. The AC3 Optimus device delivers intra-aortic balloon pump therapy to assist in pumping blood.

In October 2018, FDA approved HeartMate 3 left ventricular assist device developed by Abbott, as a destination therapy for patients with advanced heart failure. In January 2018, Canada regulatory body issued a Class IV License with conditions to HeartMate 3 Left Ventricular Assist System (LVAS) developed by Thoratec Corporation. BiVACOR Pty Ltd is developing a rotary Total Artificial Heart (TAH) device and its initiative is funded by OneVentures, a venture capital firm and the Federal Government of Australia. In addition, other leading vendors are focusing in investing huge on research and development activities to develop new products to obtain high share in the market.

Key vendors:

• Abbott Laboratories
• Berlin Heart GmbH
• Maquet GmbH (Getinge AB)
• ReliantHeart, Inc.
• SynCardia Systems, LLC
• ABIOMED, Inc.
• BiVACOR, Inc.
• Medtronic plc
• XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
• Teleflex Incorporated
• Carmat SA
• Calon Cardio-Technology Ltd.
• LivaNova, PLC

Key competitive facts

• The market is highly competitive with all the players competing to gain market share. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices of devices are some of the key factors that confront the market.
• The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.

Benefits – The report provides complete details about the current and forecast market size of every type of cardiac assist devices and market values by region. Through this report, the key stakeholders in the cardiac assist devices ecosystem can also know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:

• Understanding the potential market opportunity with precise market size and forecast data
• Detailed market analysis focusing on the growth of cardiac assist devices industry
• Factors influencing the growth of cardiac assist devices market
• In-depth competitive analysis of dominant and pureplay vendors
• Prediction analysis of cardiac assist devices industry in both developed and developing regions
• Key insights related to major segments of the cardiac assist devices market
• Latest market trend analysis impacting the buying behavior of the consumers

Contents

1 INDUSTRY OUTLOOK

1.1 Industry Overview
  1.1.1 Geography
  1.1.2 Medical Technologies
  1.1.3 Industry Trends
1.2 Total Addressable Market

2 REPORT OUTLINE

2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3 MARKET SNAPSHOT

3.1 Market Definition – Infoholic Research
3.2 Device Benefits
3.3 Segmented Addressable Market (SAM)
3.4 Trends of the Cardiac Assist Devices Market
3.5 Related Markets
  3.5.1 Interventional Cardiology
  3.5.2 Angioplasty
  3.5.3 Stents

4 MARKET OUTLOOK

4.1 Reimbursement Codes
4.2 Regulatory Status
4.3 Clinical Trials
4.4 Market Segmentation
4.5 PEST Analysis
4.6 Porter 5(Five) Forces

5 MARKET CHARACTERISTICS

5.1 DRO – Global Cardiac Assist Devices Market Dynamics
  5.1.1 Drivers
    5.1.1.1 Increasing incidence of cardiovascular device across the globe
    5.1.1.2 Lack of heart donors globally
    5.1.1.3 Increasing aged population
  5.1.2 Opportunities
    5.1.2.1 Increase in healthcare spending and demand for improved treatment in developing economies
    5.1.2.2 Robust pipeline of products
  5.1.3 Restraints
    5.1.3.1 High cost of the cardiac assist device
    5.1.3.2 Stringent regulatory policies
5.2 DRO – Impact Analysis
5.3 Key Stakeholders

6 PRODUCTS: MARKET SIZE AND ANALYSIS

6.1 Overview
6.2 Intra-Aortic Balloon Pumps
6.3 Ventricular Assist Devices
  6.3.1 Left Ventricular Assist Devices
  6.3.2 Right Ventricular Assist Devices
  6.3.3 Biventricular Assist Device (BIVAD)
6.4 Total Artificial Heart

7 REGIONS: MARKET SIZE AND ANALYSIS

7.1 Overview
7.2 North America
7.3 Europe
7.4 Asia Pacific
7.5 Rest of the World

8 COMPETITIVE LANDSCAPE

8.1 Overview

9 VENDOR PROFILES

9.1 Abbott Laboratories
  9.1.1 Overview
  9.1.2 Business Units
  9.1.3 Geographic Presence
  9.1.4 Business Focus
  9.1.5 SWOT Analysis
  9.1.6 Business Strategies
9.2 Berlin Heart GmbH
  9.2.1 Overview
  9.2.2 Business Focus
  9.2.3 SWOT Analysis
  9.2.4 Business Strategies
9.3 Maquet GmbH (Getinge AB)
  9.3.1 Overview
  9.3.2 Business Units
  9.3.3 Geographic Revenue
  9.3.4 Business Focus
  9.3.5 SWOT Analysis
  9.3.6 Business Strategies
9.4 ReliantHeart, Inc.
  9.4.1 Overview
  9.4.2 Business Focus
  9.4.3 SWOT Analysis
  9.4.4 Business Strategies
9.5 SynCardia Systems, LLC
  9.5.1 Overview
  9.5.2 Business Focus
  9.5.3 SWOT Analysis
  9.5.4 Business Strategies

10 COMPANIES TO WATCH FOR

10.1 ABIOMED, Inc.
  10.1.1 Overview
10.2 Medtronic plc
  10.2.1 Overview
10.3 BiVACOR, Inc.
  10.3.1 Overview
10.4 XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
  10.4.1 Overview
10.5 Teleflex Incorporated
  10.5.1 Overview
10.6 Calon Cardio-Technology Ltd.
  10.6.1 Overview
10.7 Carmat SA
  10.7.1 Overview
10.8 LivaNova, PLC
  10.8.1 Overview

11 ANNEXURE

11.1 Abbreviations

TABLE 1 REIMBURSEMENT CODES

ICD-10-CM DIAGNOSIS CODES THAT SUPPORT COVERAGE CRITERIA
TABLE 2 REGULATORY STATUS OF CARDIAC ASSIST DEVICES
TABLE 3 CLINICAL TRIALS
TABLE 4 GLOBAL CARDIAC ASSIST DEVICES MARKET REVENUE BY REGIONS, 2018–2025 ($MILLION)
TABLE 5 OTHER PROMINENT VENDORS OF CARDIAC ASSIST DEVICES MARKET
TABLE 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS
TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
TABLE 8 BERLIN HEART GMBH: PRODUCT OFFERINGS
TABLE 9 BERLIN HEART GMBH: RECENT DEVELOPMENTS
TABLE 10 MAQUET GMBH (GETINGE AB): OFFERINGS
TABLE 11 MAQUET GMBH (GETINGE AB): RECENT DEVELOPMENTS
TABLE 12 RELIANTHEART, INC.: OFFERINGS
TABLE 13 RELIANTHEART, INC.: RECENT DEVELOPMENTS
TABLE 14 SYNCARDIA SYSTEMS, LLC: PRODUCT OFFERINGS
TABLE 15 SYNCARDIA SYSTEMS, LLC: RECENT DEVELOPMENTS
TABLE 16 ABIOMED, INC.: SNAPSHOT
TABLE 17 ABIOMED, INC.: RECENT DEVELOPMENTS
TABLE 18 MEDTRONIC PLC: SNAPSHOT
TABLE 19 MEDTRONIC PLC: RECENT DEVELOPMENTS
TABLE 20 BIVACOR, INC.: SNAPSHOT
TABLE 21 XENIOS AG (FRESENIUS MEDICAL CARE AG & CO. KGAA): SNAPSHOT
TABLE 22 XENIOS AG (FRESENIUS MEDICAL CARE AG & CO. KGAA): RECENT DEVELOPMENTS
TABLE 23 TELEFLEX INCORPORATED: SNAPSHOT
TABLE 24 TELEFLEX INCORPORATED: RECENT DEVELOPMENTS
TABLE 25 CALON CARDIO-TECHNOLOGY LTD.: SNAPSHOT
TABLE 26 CALON CARDIO-TECHNOLOGY LTD.: RECENT DEVELOPMENTS
TABLE 27 CARMAT SA: SNAPSHOT
TABLE 28 CARMAT SA: RECENT DEVELOPMENTS
TABLE 29 LIVANOVA, PLC.: SNAPSHOT
TABLE 30 LIVANOVA, PLC: RECENT DEVELOPMENTS

CHARTS

CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION
CHART 2 RESEARCH METHODOLOGY OF GLOBAL CARDIAC ASSIST DEVICES MARKET
CHART 3 GLOBAL CARDIAC ASSIST DEVICES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 4 SEGMENTATION OF GLOBAL CARDIAC ASSIST DEVICES MARKET
CHART 5 PEST ANALYSIS OF GLOBAL CARDIAC ASSIST DEVICES MARKET
CHART 6 PORTER 5 FORCES ON GLOBAL CARDIAC ASSIST DEVICES MARKET
CHART 7 MARKET DYNAMICS – DRO ANALYSIS
CHART 8 DRO – IMPACT ANALYSIS OF GLOBAL CARDIAC ASSIST DEVICES MARKET
CHART 9 KEY STAKEHOLDERS
CHART 10 GLOBAL CARDIAC ASSIST DEVICES MARKET BY PRODUCT SEGMENTATION, 2018 (%)
CHART 11 GLOBAL CARDIAC ASSIST DEVICES MARKET BY PRODUCT SEGMENTATION, 2025 (%)
CHART 12 GLOBAL INTRA-AORTIC BALLOON PUMP MARKET FORECAST, 2018–2025 ($MILLION)
CHART 13 GLOBAL VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION)
CHART 14 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY PRODUCT TYPE SEGMENTATION, 2018 (%)
CHART 15 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY PRODUCT TYPE SEGMENTATION, 2025 (%)
CHART 16 GLOBAL LEFT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION)
CHART 17 GLOBAL RIGHT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION)
CHART 18 GLOBAL BIVENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION)
CHART 19 GLOBAL TOTAL ARTIFICIAL HEART MARKET FORECAST, 2018–2025 ($MILLION)
CHART 20 GLOBAL CARDIAC ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 (%)
CHART 21 GLOBAL CARDIAC ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2025 (%)
CHART 22 CARDIAC ASSIST DEVICES MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION)
CHART 23 CARDIAC ASSIST DEVICES MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION)
CHART 24 CARDIAC ASSIST DEVICES MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION)
CHART 25 CARDIAC ASSIST DEVICES MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION)
CHART 26 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT
CHART 27 ABBOTT LABORATORIES: BUSINESS UNITS
CHART 28 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE
CHART 29 ABBOTT LABORATORIES: SWOT ANALYSIS
CHART 30 BERLIN HEART GMBH: SWOT ANALYSIS
CHART 31 MAQUET GMBH (GETINGE AB): OVERVIEW SNAPSHOT
CHART 32 MAQUET GMBH (GETINGE AB): BUSINESS UNITS REVENUE
CHART 33 MAQUET GMBH (GETINGE AB): GEOGRAPHICAL REVENUE
CHART 34 MAQUET GMBH (GETINGE GROUP): SWOT ANALYSIS
CHART 35 RELIANTHEART, INC.: SWOT ANALYSIS
CHART 36 SYNCARDIA SYSTEMS, LLC: SWOT ANALYSIS